Phase I/II Clinical Trial Using Monoclonal Immunoconjug

Green, Mark A.

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: Division of Cancer Treatment (NCI)
• Type: Research and Development Contracts (N01)
• Project #: N01CM047672-001002
• Application #: 3612173
• Project Start: 1984-09-29
• Budget Start: 1985-07-01
• Budget End: 1985-12-30
• Fiscal Year: 1985

Institution

• Name: University of California San Diego
• Type: Schools of Medicine
• DUNS #: 077758407
• City: La Jolla
• State: CA
• Country: United States
• Zip Code: 92093

Publications

Dillman, R O; Johnson, D E; Shawler, D L et al. (1988) Superiority of an acid-labile daunorubicin-monoclonal antibody immunoconjugate compared to free drug. Cancer Res 48:6097-102

Dillman, R O; Shawler, D L; Johnson, D E et al. (1986) Preclinical trials with combinations and conjugates of T101 monoclonal antibody and doxorubicin. Cancer Res 46:4886-91